Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_assertion type Assertion NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_head.
- NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups [275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC], to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_provenance.
- NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_assertion evidence source_evidence_literature NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_provenance.
- NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_assertion SIO_000772 19643819 NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_provenance.
- NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_assertion wasDerivedFrom befree-20150227 NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_provenance.
- NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_assertion wasGeneratedBy ECO_0000203 NP339866.RAkn2MoDyLK96iUMQto0aIWnuleeg1uxk3ZKkfTZxtM2E130_provenance.